About The Study: In this study including content analysis of 27 websites across multiple countries, most websites selling direct-to-consumer Anti-Mullerian Hormone (AMH) tests included false and misleading claims which might lead consumers to purchase an AMH test in the belief that it can reliably predict fertility potential and age of menopause. Depending on the test result, this may in turn lead to misplaced anxiety or reassurance about one’s fertility and modifications to subsequent conception or contraceptive plans and behavior.
Authors: Tessa Copp, Ph.D., of the University of Sydney in Sydney, Australia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.30192)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.30192?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082123
JAMA Network Open